Clinical trial
A Study to Evaluate Ertapenem Versus It's Comparator in the Treatment of…
NCT00157898 · Merck Sharp & Dohme LLC, Industry · Completed
Key facts
| NCT number | NCT00157898 |
|---|---|
| Title | A Study to Evaluate Ertapenem Versus It's Comparator in the Treatment of Complicated Intra-abdominal Infections in Adults (0826-050)(COMPLETED) |
| Official title | A Prospective, Multicenter, Open, Randomized, Comparative Study to Evaluate the Safety and Efficacy of Ertapenem Versus it's Comparator in the Treatment of Complicated Intra-abdominal Infections in Adults |
| Lead sponsor | Merck Sharp & Dohme LLC, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Complicated Intra-abdominal Infection |
| Intervention type | Drug |
| Interventions | MK0826, ertapenem sodium, Comparator: ceftriaxone + metronidazole |
| Enrollment | 134 |
| Start date | Jan 1, 2004 |
| Primary completion | Aug 1, 2004 |
| Completion | Sep 1, 2004 |
| First posted | Sep 12, 2005 |
| Last update posted | Feb 20, 2017 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: